Qube Research & Technologies LTD I Bio, Inc. Transaction History

Qube Research & Technologies LTD

  • $62.3 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.23 - $160.0 $4,095 - $2.85 Million
-17,807 Reduced 9.96%
160,989 $27,000
Q2 2022

Aug 15, 2022
BUY
$0.23 - $0.46 $41,123 - $82,246
178,796 New
178,796 $47,000
Q1 2022

May 09, 2022
SELL
$0.3 - $0.61 $65,314 - $132,806
-217,716 Closed
0 $0
Q4 2021

Feb 01, 2022
BUY
$0.55 - $1.04 $119,743 - $226,424
217,716 New
217,716 $120,000

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email